Beam Therapeutics Inc logo

Beam Therapeutics Inc

Beam Therapeutics Inc. operates as a clinical-stage biotechnology company, which develops base editing technology to treat serious diseases by making precise changes to DNA and RNA. Its portfolio includes target genes that cover oncology, hematology, ophthalmology, liver disease and neurology conditions. The company was founded by David Nelles, Matthew Porteus and Feng Zhang on April 10, 2018 and is headquartered in Cambridge, MA.

Latest events on Quartr

Previous Events for Beam Therapeutics Inc

Ticker

BEAM

Country

United States of America

About the company

https://beamtx.com/about-us/

Investor Relations page

https://investors.beamtx.com/

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot